Renvela may react with vitamins as well:
5 WARNINGS AND PRECAUTIONS
5.3 Monitor for Reduced Vitamins D, E, K (clotting factors) and Folic Acid Levels
12.2 Pharmacodynamics
In addition to effects on serum phosphate levels, sevelamer hydrochloride has been
shown to bind bile acids in vitro and in vivo in experimental animal models. Bile acid
binding by ion exchange resins is a well-established method of lowering blood
cholesterol. Because sevelamer binds bile acids, it may interfere with normal fat
absorption and thus may reduce absorption of fat soluble vitamins such as A, D and K.
In clinical trials of sevelamer hydrochloride, both the mean total and LDL cholesterol
declined by 15-31%. This effect is observed after 2 weeks. Triglycerides, HDL cholesterol
and albumin did not change.
7. DRUG INTERACTIONS
... When administering an oral medication where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy, the drug should be administered at least one hour before or three hours after Renvela, or the physician should consider monitoring blood levels of the drug. Patients taking antiarrhythmic medications for the control of arrhythmias and anti-seizure medications for the control of seizure disorders were excluded from the clinical trials. Special precautions should be taken when prescribing Renvela to patients also taking these medications.
http://www.renvela.com/docs/renvela_PI.pdf Just remember, we always need to weight the "good and not so good" aspects of the phosphate binders we use.